Le Lézard
Classified in: Health, Covid-19 virus
Subjects: BFA, POL, AVO

Doctors Hampered from Saving Patients by Imposed Standard of Care Protocols


ST. PAUL, Minn., May 26, 2020 /PRNewswire/ -- Citizens' Council for Health Freedom (CCHF) resonates with the complaints of physicians frustrated in their care of COVID-19 patients by 'evidence-based medicine' and bureaucratic restraints imposed by outside third-parties.

Evidence-based medicine (EBM), a term advanced by Canadian physician David Sackett, was introduced as a way to appraise medical literature. It was never intended to restrict the medical choices of physicians, but government and other third-party payers often use it to limit patient access to care.

"Evidence-based medicine protocols can act like handcuffs, preventing the proper care of patients," said Twila Brase, president and co-founder of CCHF, and author of two reports on EBM. "To save his patients from EBM protocols, New York City physician, Dr. Cameron Kyle-Sidell, made a public plea online for every hospital to change ventilator protocols because they were damaging lungs. But why did he, a physician, even have to ask for permission?"

As a result of the protocols, Dr. Kyle-Sidell told MedScape he had to step down from the ICU: "We ran into an impasse where I could not morally, in a patient-doctor relationship, I could not continue the current protocols which, again, are the protocols of the top hospitals in the country."

The New York Times released a video of several physicians nationwide who are questioning the one-size-fits-all treatment protocols and are concerned about harming their patients. Only one physician interviewed said physicians should not deviate from these protocols. The other physicians were already leaving them behind, clearly trying to save their patients rather than being worried about repercussions from the institutions that employ them.

"COVID-19 has drawn attention to the dangers of one-size-fits-all evidence-based medicine protocols," said Brase. "Thankfully many doctors are throwing EBM to the wind to save their COVID-19 patients. They're talking to each other cross-country by Zoom and ignoring prescriptive third-party protocols that don't work for patients. This 'freedom to treat' should not change when COVID-19 is over."

As evidence of successful care counter to current protocols, CCHF points to physicians delaying use of ventilators, putting people in respiratory distress on their stomachs in prone position with low flow oxygen, sharply reducing standard ventilator pressures to reduce lung damage, and prescribing hydroxychloroquine to keep patients from facing hospitalization and ventilation.

SOURCE Citizens' Council for Health Freedom


These press releases may also interest you

at 16:10
The global consumer healthcare market size is estimated to grow by USD 170.2 billion from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of 6.78% during the forecast period. Awareness about lifestyle diseases is driving...

at 16:01
On the Fourth of July, American Independence Day, the American Association of Kidney Patients (AAKP) announced the rapid success and growing impact of its 2024 non-partisan KidneyVotertm registration drive. On June 19, Flag Day, AAKP kicked off its...

at 15:20
Team famous for HIV breakthroughs demonstrates both persistent COVID virus and widespread immune activation in long COVID; provides clear targets for treatment Key points: SARS-CoV-2 double-stranded RNA indicative of viral replication was found in...

at 15:10
The Board of Directors of FS Credit Opportunities Corp. (the Fund) announced the monthly distribution for July 2024. The distribution of $0.06 per share will be paid on July 31, 2024. Further information on the distribution is summarized in the...

at 15:00
Key PointsLance Foos, an Ohio National Guard Brigade Plans Officer and Marathon Petroleum employee, balanced military duties with civilian responsibilities, showcasing resilience and dedication.Throughout challenging times of deployment, Foos's...

at 14:55
The global anti-inflammatory therapeutics market size is estimated to grow by USD 38.7 billion from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of over 6.3% during the forecast period. Increase in off-label use is...



News published on and distributed by: